Q1 2018 EPS Estimates for Cabot Corp Decreased by Analyst (CBT)

Cabot Corp (NYSE:CBT) – Stock analysts at Jefferies Group decreased their Q1 2018 EPS estimates for Cabot in a research report issued to clients and investors on Monday. Jefferies Group analyst L. Alexander now expects that the specialty chemicals company will post earnings of $0.86 per share for the quarter, down from their prior forecast of $0.95. Jefferies Group has a “Buy” rating and a $74.00 price target on the stock. Jefferies Group also issued estimates for Cabot’s Q3 2018 earnings at $0.93 EPS, Q4 2018 earnings at $1.01 EPS and FY2018 earnings at $3.80 EPS.

Cabot (NYSE:CBT) last released its quarterly earnings data on Tuesday, October 31st. The specialty chemicals company reported $0.91 earnings per share for the quarter, missing the consensus estimate of $0.93 by ($0.02). The business had revenue of $723.00 million during the quarter, compared to analyst estimates of $683.30 million. Cabot had a net margin of 8.87% and a return on equity of 15.11%. The business’s quarterly revenue was up 16.8% compared to the same quarter last year. During the same period last year, the business earned $1.00 earnings per share.

Other analysts have also issued reports about the company. KeyCorp reaffirmed a “hold” rating on shares of Cabot in a research note on Wednesday, November 1st. SunTrust Banks raised Cabot from a “hold” rating to a “buy” rating in a research note on Tuesday, December 19th. Loop Capital raised Cabot from a “hold” rating to a “buy” rating and set a $82.00 price target on the stock in a research note on Friday, January 5th. Zacks Investment Research lowered Cabot from a “buy” rating to a “hold” rating in a research note on Thursday, January 18th. Finally, ValuEngine raised Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $70.67.

Cabot (NYSE CBT) traded up $0.27 during trading hours on Tuesday, reaching $67.85. The company had a trading volume of 587,800 shares, compared to its average volume of 436,200. The firm has a market capitalization of $4,186.56, a price-to-earnings ratio of 17.81, a PEG ratio of 1.78 and a beta of 1.11. The company has a quick ratio of 1.17, a current ratio of 1.70 and a debt-to-equity ratio of 0.41. Cabot has a fifty-two week low of $50.21 and a fifty-two week high of $68.08.

The company also recently declared a quarterly dividend, which will be paid on Friday, March 9th. Stockholders of record on Friday, February 23rd will be paid a dividend of $0.315 per share. This represents a $1.26 dividend on an annualized basis and a dividend yield of 1.86%. The ex-dividend date is Thursday, February 22nd. Cabot’s payout ratio is 33.07%.

Several hedge funds have recently made changes to their positions in the company. Ameritas Investment Partners Inc. raised its position in shares of Cabot by 2.0% during the second quarter. Ameritas Investment Partners Inc. now owns 18,696 shares of the specialty chemicals company’s stock worth $999,000 after acquiring an additional 363 shares during the last quarter. Gratus Capital LLC raised its position in shares of Cabot by 9.9% during the third quarter. Gratus Capital LLC now owns 8,853 shares of the specialty chemicals company’s stock worth $494,000 after acquiring an additional 800 shares during the last quarter. Pacer Advisors Inc. raised its position in shares of Cabot by 11.5% during the third quarter. Pacer Advisors Inc. now owns 9,232 shares of the specialty chemicals company’s stock worth $515,000 after acquiring an additional 950 shares during the last quarter. PNC Financial Services Group Inc. raised its position in shares of Cabot by 12.8% during the second quarter. PNC Financial Services Group Inc. now owns 10,652 shares of the specialty chemicals company’s stock worth $571,000 after acquiring an additional 1,205 shares during the last quarter. Finally, Mutual of America Capital Management LLC raised its position in shares of Cabot by 3.3% during the second quarter. Mutual of America Capital Management LLC now owns 50,196 shares of the specialty chemicals company’s stock worth $2,682,000 after acquiring an additional 1,617 shares during the last quarter. 84.79% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: This news story was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another domain, it was copied illegally and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this news story can be read at https://www.americanbankingnews.com/2018/01/23/q1-2018-eps-estimates-for-cabot-corp-decreased-by-analyst-cbt.html.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Earnings History and Estimates for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply